COVID-19

Coronavirus can attack your gut as well as your lungs. This is what we know so far

Security personnel who are dressed in PPE (Personal Protective Equipment) stand at a check-in area  at Changi Exhibition Centre which has been repurposed into a community isolation facility that will house recovering or early COVID-19 patients with mild symptoms, during the coronavirus disease (COVID-19) outbreak, in Singapore April 24, 2020. Picture taken April 24, 2020. REUTERS/Edgar Su - RC24CG9G9I84

It's not just your lungs at risk. Image: REUTERS/Edgar Su - RC24CG9G9I84

Martin Veysey
Programme Director MBBS, Hull York Medical School, University of York
Share:
Our Impact
What's the World Economic Forum doing to accelerate action on COVID-19?
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

COVID-19

  • COVID-19 patients offer suffer from gastrointestinal symptoms, as well as, or instead of, respiratory issues.
  • The molecule which the virus attacks in our bodies is present not just in our lungs, but in our gastrointestinal tract as well.

When we think of the symptoms of coronavirus, we think of the lungs – people on ventilators or with nasty coughs, struggling to breathe. That’s because a COVID-19 positive patient often presents with fever, persistent cough, muscle pain and fatigue.

But the molecule which the virus attacks in our bodies – Angiotensin Converting Enzyme 2 or ACE2 – is present not just in our lungs, but in our gastrointestinal tract as well. This is what could be behind the significant number of cases in which patients show gastrointestinal symptoms such as diarrhoea, nausea and vomiting.

A recent commentary in Gut, a British Medical Journal publication, highlighted important evidence from China which showed that if a patient presents with gastrointestinal issues, like diarrhoea, nausea and vomiting, more than a quarter of them may not have respiratory symptoms.

Unlike previous work, which had shown that less than 4% of COVID-19 patients had gastrointestinal symptoms, this study put the rate at 11%. Others have suggested that the rate may be as high as 60%.

Patients with gastrointestinal symptoms may develop more serious forms of the disease, according to emerging research.
Patients with gastrointestinal symptoms may develop more serious forms of the disease, according to emerging research. Image: Stephania Lecocq/EPA

In these small studies, the researchers also linked patients with gastrointestinal presentations to poorer outcomes. When they compared them to those without gastrointestinal symptoms, patients had more severe disease, higher fevers and a greater risk of liver injury.

In a separate study of those with a mild form of COVID-19, researchers compared those who had gastrointestinal or respiratory symptoms, or both, with those presenting only with respiratory symptoms. They found that 23% of patients had gastrointestinal presentations alone, while 57% had both a gut and a respiratory illness. It also took longer for those with digestive symptoms to clear the virus.

Gut invaders

It is interesting to note that the first case of novel coronavirus reported in the US had two days of nausea and vomiting and episodes of diarrhoea in addition to their respiratory symptoms. The virus was detected in samples from this patient’s nose, their throat but also isolated from stool samples collected.

There are a number of symptoms associated with COVID-19.
There are a number of symptoms associated with COVID-19. Image: King's College London

Analysis of specimens taken from the gastrointestinal tract of 95 COVID-19 patients has identified the virus in the oesophagus, stomach, duodenum and rectum. The virus also showed up in about half of the stool samples collected.

The suggestion is that the gastrointestinal symptoms are caused by the virus invading the ACE2-containing cells that are found throughout the bowel. This together with the presence of the virus in the stool suggest the gastrointestinal tract as another possible route of infection and transmission.

It appears that SARS-CoV-2 is detectable in the stool for several days after it has cleared from respiratory tract samples. So patients who have recovered from COVID-19 or are asymptomatic could be shedding virus into their stool without knowing it, potentially increasing the risk of transmission to others.

Why your microbiome matters

Why do symptoms in your gut mean you might get a worse case of COVID-19? It’s likely that the composition of your microbiome – the millions of bacteria and other organisms that usually live in our gastrointestinal tract – is a critical part of how an individual responds to COVID-19.

One group of researchers created a risk score based on biomarkers in the blood that can be increased or decreased depending on the composition of your microbiome. They found that the higher the score, the worse the outcome from COVID-19. This association was stronger for older individuals. It may be that the health of our gut bacteria has a critical role in how our immune system reacts to the disease.

So it’s important to maintain a healthy microbiome to fight COVID-19.

How do you do that? The key is to eat to feed your microbiome. Eating plant-based food you cook yourself and limiting ultra-processed and take-away foods are to be commended, while supplementing your diet with natural probiotics such kombucha, kimchi and natural yoghurt. This will optimise your microbiome, not just for COVID-19, but for your long-term health as well.

Have you read?

Gut feeling

With the pandemic continuing, we should all pay more attention to our guts. Much of the focus to date has been on ventilators, intensive care and the respiratory consequences of the novel coronavirus infection. However, if you have new onset sickness and vomiting or diarrhoea, and no other explanation, it may be COVID-19 and you may need to seek help.

And if it’s true that the gastrointestinal tract is another source for virus transmission in both symptomatic and asymptomatic individuals, it remains paramount that people follow the advice to stay home and stay safe with a combination of shielding, social distancing and regular hand-washing.

Finally, it is worth considering how to maintain a healthy microbiome in these challenging and unprecedented times – eating well may just make a difference to your COVID-19 outcome.

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
COVID-19Global HealthHealth and Healthcare
Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Winding down COVAX – lessons learnt from delivering 2 billion COVID-19 vaccinations to lower-income countries

Charlotte Edmond

January 8, 2024

About Us

Events

Media

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2024 World Economic Forum